204118-35-4

Basic information

• Product Name: 2(1H)-Pyridinone,5,6-dihydro-3,4-dimethyl-(9CI)
• Synonyms: 2(1H)-Pyridinone,5,6-dihydro-3,4-dimethyl-(9CI);3,4-DIMETHYL-5,6-DIHYDROPYRIDIN-2(1H)-ONE
• CAS NO: 204118-35-4
• Molecular Formula: C₇H₁₁NO
• Molecular Weight: 125.17
• Product Categories: PIPERIDINE
• Mol File: 204118-35-4.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 2(1H)-Pyridinone,5,6-dihydro-3,4-dimethyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2(1H)-Pyridinone,5,6-dihydro-3,4-dimethyl-(9CI)(204118-35-4)
• EPA Substance Registry System: 2(1H)-Pyridinone,5,6-dihydro-3,4-dimethyl-(9CI)(204118-35-4)

Safety Data

• Hazardous Substances Data: 204118-35-4(Hazardous Substances Data)

Usage

Structure

A heterocyclic compound with a six-membered ring consisting of five carbon atoms and one nitrogen atom.

Physical state

Colorless liquid

Odor

Distinct

Solubility

Insoluble in water, soluble in organic solvents

Uses

Precursor for the synthesis of other organic compounds, potential applications in pharmaceuticals, agrochemicals, and other industries

Health risks

May pose health risks if not handled properly, proper safety precautions should be taken.

Upstream product

• 1121-05-7 2,3-dimethylcyclopent-2-enone 

Relevant articles and documents

Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Synthesis and biological evaluation of dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines

The process of discovery and biological evaluation of α,β-unsaturated cyclic amidines, as selective inhibitors of inducible nitric oxide synthase (iNOS), is reported. Dihydropyridin-2(1H)-imines and 1,5,6,7-tetrahydro-2H-azepin-2-imines were synthesized a

Design and synthesis of orally bioavailable inhibitors of inducible nitric oxide synthase. Part 1: Synthesis and biological evaluation of dihydropyridin-2-imines

Dihydropyridin-2-imines were synthesized and biologically evaluated both in vitro and in vivo using a nitric oxide inhibition assay. Compounds 1, 4, 5 and 7-11 exhibited potent activity in the inducible nitric oxide (iNOS) inhibition assay. Of these 5, 6,